The new data could broaden the clinical use of palbociclib – and other drugs that work in the same way – beyond breast cancer to include many other tumour types as well.
News
BMJ data suggests link between sugary drinks and cancer
100 ml increase in sugary drinks each day was associated with an 18% increased risk of overall cancer and a 22% increased risk of breast cancer.
FDA set to review Sanofi’s isatuximab for multiple myeloma
Multiple myeloma is the second most common hematologic malignancy, affecting more than 138,0002 people worldwide.
Nursing degree applications at ‘crisis point’
Applications in England have fallen 29% since the bursary was removed in 2016.
NIHR to invest £135m to tackle system challenges
The five-year plan will join up some of the country’s best universities, leading innovators and local authorities to solve some of the biggest issues facing health and social care.
NICE recommends gammaCore for cluster headaches
The portable technology aims to modify pain signals by stimulating the vagus nerve through the skin of the neck.
HPV vaccine to be offered to school-age boys
Girls have been offered the jab free from the NHS since 2008.
NHS improvements can’t happen ‘overnight’, says NHS Confederation
The King’s Fund Quarterly Monitoring Report suggested that patients face a long wait before they will see improvements in care as a result of the government’s £20 billion NHS funding boost.
GSK’s Dovato hits endpoints in late-stage study
In a Phase III study the drug combo was as effective in controlling HIV-1 as a Vemlidy combo.
Amazon’s Alexa to offer NHS healthcare advice
Amazon’s algorithm will use information from the NHS website to provide the answers.
Pharma industry invests £377m in UK R&D collabs
ABPI chief said that the investment from companies is “excellent news at a time of economic uncertainty and signals the strength of the sector in the UK.”
Healthcare regulators to gain autonomy
The new release outlines how the regulation of healthcare workers will better support professionals and modern fitness to practise processes.
An exciting new opportunity & reward for finalists of the 2019 Sales Awards
PharmaTimes have partnered with the Applied Healthcare Academy for the 2019 Sales Awards to give entrants and winners an added bonus for their success.
Roche presents positive late-stage Hemlibra data
Haemophilia A is an inherited, serious disorder in which a person’s blood does not clot properly.
AMR pushes NHS to trial ‘subscription-style’ payment model
Companies are set to be paid based on the value the medicine brings to the NHS.
